No Data
No Data
West Holdings, Yasue Construction, etc. (part 1)
As of July 31, 2024, the shareholding ratio of Kabushiki Kaisha West Holdings Asset Management One Kabushiki Kaisha was reduced from 8.42% to 5.67%. As of August 1, 2024, the shareholding ratio of Kabushiki Kaisha Yasue Komuten Macquarie Bank Limited was reduced from 18.00% to 17.89%. Kabushiki Kaisha Kitahama Capital Partners is not fully represented.
Mitsui Sumitomo DS Asset Management increases its stake in Soken Chemical & Engineering(4972.JP) to 6.06%
On Aug 7, Mitsui Sumitomo DS Asset Management and related parties submitted the Change Report to Ministry of Finance. The report shows that Mitsui Sumitomo DS Asset Management and related parties
Investment strategy for today, August 6th.
[Fisco Selected Brands] [Material Brands] Soiken Holdings Co., Ltd.<4972> 2,100 yen (as of 8/5) deals with acrylic pressure-sensitive adhesives, special functional materials, functional particles, tape and film processing products, and more. The first-half performance forecast has been raised. The operating profit estimate is 3.85 billion yen (2.3 times the previous year's same period). It has been raised to more than double the previous estimate. Sales of the main product, adhesive, which is centered on China, have exceeded initial expectations. The results forecast for the fiscal year ending March 2025 is under review. Current operating profit
Itochu's operating profit for the first quarter increased by 13.9% to 190.5 billion yen.
Itochu (8001) announced its first quarter results for the March 2025 fiscal year, with revenue of 3.598918 trillion yen, a 7.5% increase compared to the same period of the previous year, while operating profit increased by 13.9% to 190.539 billion yen.
Soken Chemical & Engineering: Consolidated financial results for the first quarter ending March 2025 (based on Japanese standards)
Soken Chemical & Engineering: Announcements of individual stocks regarding the revision of financial estimates for the second quarter (cumulative) of the March 2025 term.
No Data
No Data